Overview
The Marathon of Hope Cancer Centres Network (MOHCCN) is a national network of cancer centres that pursue collaborative cancer research in precision medicine (an emerging approach for disease treatment and prevention that considers individual variability in DNA, environment and lifestyle) to accelerate the discovery of innovations and improve the health outcomes for cancer patients
Description
The purpose of this study is to use evolving technologies such as genomics and artificial intelligence to study cancer so that the right treatment can be given to the right patient, at the right time. Approximately 15,000 participants will take part in the greater MOHCCN study across Canada in the first 5 years, and ultimately the goal is to enroll up to 100,000 over next 10 years.
Eligibility
Inclusion Criteria:
- Patients with histological and cytological confirmation of blood or solid tumor malignancies.
- All patients must be able to satisfy the required minimum data elements for the 15k
gold standard cohort through:
- existing data that satisfies the minimal requirements of a gold standard case, AND/OR
- previously collected and sufficient biospecimens (tumor and/or blood samples) for whole-genome and transcriptome sequencing and immunophenotype characterization, AND/OR
- new blood collection and/or tumor biopsy
- Agrees to share anonymized clinical and genomic data.
Exclusion Criteria:
None.